secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2025-09-09T23:59:59+00:00
Accession:  0001171843-25-005800
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech files prospectus supplement for up to $4.0M ATM offering through H.C. Wainwright
--------------------------------------------------------------------------------

- ATM offering for up to $4,006,544 of common shares through H.C. Wainwright.
- Previously sold $837,134 under existing ATM agreement from October 2024.
- New shelf registration statement (S-3, File No. 333-288966) declared effective September 9, 2025.
- Legal opinion from Fasken Martineau DuMoulin LLP on share validity included as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000117184325005800/0001171843-25-005800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000117184325005800/f8k_090925.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-005800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer